Jeffrey T. L. Smith, EVP & Chief Medical Officer at Zymeworks Inc. (ZYME), sold 21,076 shares at $25.10 ($529K) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Open-market sale of $529k ZYME by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.10 | 10,538 | $264K | 50.0% |
| 2 | $25.10 | 10,538 | $265K | 50.0% |
| Total | $25.10 avg | 21,076 | $529K | 100% |
| Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |
| ALDR | SELL | 2018-11-05 | $135K | — | Filing → |